Adeniyi-Jones S K, Karnovsky M L
J Clin Invest. 1981 Aug;68(2):365-73. doi: 10.1172/jci110264.
The oxidative decarboxylation of amino acids by a system consisting of myeloperoxidase-hydrogen peroxide-chloride has been demonstrated previously by others and the process has been considered to be part of the microbicidal armamentarium of some phagocytic leukocytes. We were able to translate these earlier observations, made on model systems, to intact guinea pig granulocytes. We could demonstrate differences in the cellular handling of peptide-linked amino acids as particles, compared with free amino acids. Specific inhibitors were used to explore two routes of oxidative decarboxylation: (a) the myeloperoxidase-catalyzed direct decarboxylation-deamination reaction, and (b) oxidation of alpha-keto acids after transamination of amino acids. These inhibitors were cyanide, azide, and tapazole for the former pathway, and amino-oxyacetate for the latter. Amino-oxyacetate profoundly inhibited the decarboxylation of free 14C-amino acids (alanine and aspartate) in both resting and stimulated cells, but had only a minimal effect on 14CO2 production from ingested insoluble 14C-protein. On the other hand, the peroxidase inhibitors cyanide, azide, and tapazole dramatically inhibited the production of 14CO2 from ingested particulate 14C-protein, but had only small effects on the decarboxylation of free amino acid. Soluble, uniformly labeled 14C-protein was not significantly converted to 14CO2 even in the presence of phagocytizable polystyrene beads. These observation suggest that the amino acids taken up by phagocytosis (e.g., as denatured protein particles) are oxidatively decarboxylated and deaminated in the phagosomes by the myeloperoxidase-hydrogen peroxide-chloride system; soluble free amino acids that enter the cytoplasm by diffusion or transport are oxidatively decarboxylated after transamination by the normal cellular amino acid oxidative pathway.
其他人之前已证明,由髓过氧化物酶 - 过氧化氢 - 氯化物组成的系统可使氨基酸发生氧化脱羧反应,该过程被认为是某些吞噬性白细胞杀菌武器库的一部分。我们能够将这些先前在模型系统上所做的观察结果应用于完整的豚鼠粒细胞。与游离氨基酸相比,我们可以证明细胞对肽连接氨基酸作为颗粒的处理方式存在差异。使用特定抑制剂来探究氧化脱羧的两条途径:(a) 髓过氧化物酶催化的直接脱羧 - 脱氨反应,以及 (b) 氨基酸转氨后α - 酮酸的氧化。前者途径的抑制剂是氰化物、叠氮化物和他巴唑,后者途径的抑制剂是氨基氧乙酸。氨基氧乙酸在静息和受刺激的细胞中均显著抑制游离14C - 氨基酸(丙氨酸和天冬氨酸)的脱羧,但对摄入的不溶性14C - 蛋白质产生的14CO2影响极小。另一方面,过氧化物酶抑制剂氰化物、叠氮化物和他巴唑显著抑制摄入的颗粒状14C - 蛋白质产生14CO2,但对游离氨基酸的脱羧影响较小。即使存在可吞噬的聚苯乙烯珠,可溶性、均匀标记的14C - 蛋白质也不会显著转化为14CO2。这些观察结果表明,通过吞噬作用摄取的氨基酸(例如作为变性蛋白质颗粒)在吞噬体中被髓过氧化物酶 - 过氧化氢 - 氯化物系统氧化脱羧和脱氨;通过扩散或转运进入细胞质的可溶性游离氨基酸在经正常细胞氨基酸氧化途径转氨后被氧化脱羧。